ATANIS Biotech

Sursee, Switzerland Founded: 2021 • Age: 5 yrs
Developer of a cell-based assay for the diagnosis of allergies
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About ATANIS Biotech

ATANIS Biotech is a company based in Sursee (Switzerland) founded in 2021 by Thomas Kaufmann, Alexander Eggel, Noemi Bachmeier Zbaren, and JeanPierre Kinet. ATANIS Biotech offers products and services including FAST-PASE®. ATANIS Biotech operates in a competitive market with competitors including Altis Biosystems, Allergy Amulet, YorkTest, Toxys and Inovotion, among others.

  • Headquarter Sursee, Switzerland
  • Founders Thomas Kaufmann, Alexander Eggel, Noemi Bachmeier Zbaren, JeanPierre Kinet
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Atanis Biotech Ag
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ATANIS Biotech

ATANIS Biotech offers a comprehensive portfolio of products and services, including FAST-PASE®.

Product name locked
Category locked
Primary

A tool for fast and reliable functional allergy screening services.

Funding Insights of ATANIS Biotech

Investors in ATANIS Biotech

ATANIS Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Spectrum Value Management.

All
Institutional
Investor Description Founded Year Domain Location
Provides wealth management and advisory services for family investments.
Locked Locked Locked
Premium access

Investor details for ATANIS Biotech

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ATANIS Biotech

Investments
Premium access

Investment portfolio details for ATANIS Biotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ATANIS Biotech

Premium access

Detailed financials for ATANIS Biotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Atanis Biotech Comparisons

ATANIS Biotech Primary company
Description
Developer of a cell-based assay for the diagnosis of allergi...
Location
Sursee, Switzerland
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ATANIS Biotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ATANIS Biotech

ATANIS Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altis Biosystems, Allergy Amulet, YorkTest, Toxys and Inovotion, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of invitro platform for drug testing
Locked Locked Locked
Portable food allergen sensors are offered via an online platform.
Locked Locked Locked
At-home food and allergy test kits are developed by YorkTest.
Locked Locked Locked
In vitro genotoxicity testing services are provided using proprietary technology.
Locked Locked Locked
Provider of in vivo oncology efficacy and toxicity assays for drug discovery and development
Premium access

Detailed competitors of ATANIS Biotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Atanis Biotech

Premium access

Complete news archive for ATANIS Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ATANIS Biotech

ATANIS Biotech was founded in 2021 and raised its 1st funding round 3 years after it was founded.

ATANIS Biotech is headquartered in Sursee, Switzerland. It is registered at Sursee, Luzern, Switzerland.

JeanPierre Kinet is the current CEO of ATANIS Biotech. They have also founded this company.

ATANIS Biotech was founded in 2021 in Sursee, Switzerland, within the biotechnology sector focused on allergy diagnostics. A cell-based assay is developed through FAST-PASE technology to replicate allergic reactions in vitro, thereby isolating patients from allergens during testing. Operations center on advancing diagnostic tools for safer allergy identification, with leadership provided by co-founders including JeanPierre Kinet as CEO and Noemi Bachmeier Zbaren as Managing Director.

ATANIS Biotech's top competitors include Allergy Amulet, Altis Biosystems and ABL Diagnostics.

ATANIS Biotech offers FAST-PASE®.

ATANIS Biotech has 1 investor. Key investors include Spectrum Value Management.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available